| |
|
| |
| Links: |
The liver is one of the most important organs of the human body and performs major functions, such as removal of harmful substances from blood, maintains adequate level of chemicals in the body and stores nutrients for all cellular and biological activities.
Improper functioning of liver cause many severe diseases, such as hepatitis A, B, C, Primary Biliary Cirrhosis and tumors. Some inherited diseases, such as Wilson’s Disease, Alagille Syndrome and Hemochromatosis are also occurred by improper functioning of liver.
Some of the major reasons for improper functioning of liver are genetic disorder, excessive alcohol consumption and obesity. Some of these may also lead to permanent damage of liver.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2831
The global market of liver disease treatment is categorized based on various drugs type and by disease. The drug type segment is further sub-segmented in vaccines, antiviral, corticosteroids, anabolic steroids, antimetabolites, anti-rejection drugs, immunosuppressive agents, immune globulins and chemotherapy.
The antiviral drug represents the largest sub-segment in global liver disease treatment market. Moreover, the disease segment includes hepatitis, autoimmune diseases, liver tumor, alcohol induced liver disease, chronic liver disease and non-alcoholic fatty liver disease. The treatment of hepatitis is the largest and fastest growing sub-segment in global liver disease treatment market.
Under geographic analysis, North America is the largest market for liver disease treatment drugs followed by Europe and Asia. In North America, the U.S. represents the largest market for liver disease treatment drugs. In Europe, Germany, France and the U.K. covers the major share of liver disease treatment market.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2831
Moreover, Asia represents the fastest growing market for liver disease treatment drugs, due to increasing geriatric populations. The liver has a significant ability to regenerate and maintain function in elderly age. However, changes in cellular and physiological function during aging inhibit the normal function of the liver and cause diseases.
Furthermore, Asia is one of the strong oncology markets accounting for nearly half of all new cancer cases in the world. These increasing cases of cancer also comprise liver cancers. This increasing number of liver cancer cases in the Asian countries requires huge amount of liver disease treatment drugs for prevention and treatment of liver cancer and tumors.
Globally, liver disease treatment market is growing with moderate growth rate due to aging population, excessive alcohol consumptions and increasing prevalence of liver diseases.
Moreover, high unmet needs for the treatment of liver cancer also supports in growth of liver disease treatment market. However, side-effects and risk associated with medications impede growth of the liver disease treatment market.
Moreover, stringent FDA approvals procedure and other government regulations also impede growth of the liver disease treatment market. Furthermore, availability of alternate treatment procedure is one of the key challenge for global liver disease treatment market.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2831
Some of the key companies operating in the liver disease treatment market are Abbott Laboratories, Actavis Inc., Aton Pharma, Bayer Schering AG, Biotest, Bristol-Myers Squibb, Eli Lilly, Forest laboratories, Inc., Glaxosmithkline PlC, Merck & Co., Mylan, Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda Pharmaceuticals and Zydus Pharmaceuticals Inc.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 10 Rating: 0.00 Votes: 0) Rate ItThe term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors.
Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from IVIg to maintain the appropriate level of antibodies in the body.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2830
The global market of IVIg is categorized based on plasma protein and by therapeutic area. The plasma protein segment is further sub-segmented in polyvalent IVIg, albumin, Factor VIII, hyperimmunes (IM&IV) and Factor IX. Polyvalent IVIg sub-segment holds the largest market share in global IVIg market.
Moreover, the therapeutic area segment includes immune deficiencies, autoimmune diseases and acute infections. The immune deficiency sub-segment comprises major diseases, such as, hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia and acquired compromised immunity conditions (secondary immune deficiencies), featuring low antibody levels.
The autoimmune disease sub-segment includes immune thrombocytopenia (ITP) and Inflammatory diseases.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2830
In terms of geography, North America is the largest market for IVIg followed by Europe and Asia. In North America, the U.S. represents the largest market for IVIg. In Europe, Germany, France and the U.K. covers the major share of IVIg market. Asia represents the fastest growing market for IVIg, due to increasing aging population. Elderly people are more susceptible to antibody deficiency diseases.
Globally, IVIG market is witnessing a strong growth due to increasing number of patients with bleeding disorders, rising geriatric population and increasing number of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients.
Moreover, increasing investment in healthcare sector is also supporting in growth of IVIg market. In addition, increasing number of patients suffering with autoimmune diseases and other pathological conditions are also supporting growth of IVIg products in the market.
However, stringent regulations hamper the growth of the IVIg market. Several government associations have imposed strict guidelines for appropriate usage of IVIg products. For instance, Canadian Blood Services and National Advisory Committee on Blood and Blood Products of Canada provide practice guidelines on the usage of IVIg products in hematological diseases.
In addition, high treatment cost also impedes growth of IVIg market. Some patients cannot afford IVIg products, due to high cost of their treatment. IVIg products are very expensive as the materials required to produce them cost more and the manufacturing process requires a significant amount of blood samples from donors.
The collection of large amount of blood samples is a very complex and tedious process. Furthermore, high risks of side-effects associated with IVIg treatment also restrain growth of the IVIg market. Some of the major side-effects of IVIg treatment are headache, migraine, dizziness, fever, nausea, vomiting, fast heart rate, itching, high blood pressure, cough and abdominal pains. These side-effects inhibit the acceptance of IVIg products by many patients.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2830
Some of the key players operating in IVIg market are Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Guizhou Taibang Biological Products Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Octapharma AG, Grifols, S.A, Hualan Biological Engineering Inc., OMRIX Biopharmaceuticals Ltd. and Kedrion S.p.A.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 9 Rating: 0.00 Votes: 0) Rate ItOphthalmology is the branch of medicines which deals with anatomy, physiology and diseases of the eye. Some of the major eye diseases include haloes, distorted vision, eyelid abnormalities, glaucoma, retinal disease and cataract.
The ophthalmology device market is categorized based on various diagnostic and monitoring devices, surgical devices and vision care products. These segments comprise several devices used for treatment of eye diseases.
The diagnostic and monitoring device segment is further sub-segmented into fundus cameras, pachymeters, specular microscopes, optical coherence tomography scanners, keratometers, ophthalmic ultrasound imaging systems, wavefront aberrometers, tonometers, slit lamps and corneal topographers.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2825
The surgical device segment includes refractive device, vitreoretinal surgery device, cataract and glaucoma devices. The vision care segment comprises spectacles and contact lenses.
North America is the largest market for ophthalmology devices market followed by Europe and Asia. Asia is the fastest growing market for ophthalmology devices due to increasing number of eye surgeries for treatment of eye diseases.
Moreover, many government initiatives are supporting in growth of ophthalmology devices market in the Asian countries.
Global ophthalmology device market has emerged as one of the growing segments in medical devices market, due to increased demand of ophthalmology devices for treatment of eye diseases.
Moreover, increasing prevalence of eye disorders, aging population, increasing government investment towards research activities and technical advancements are some of the key drivers for ophthalmology device market. Developing counties, such as China and India, have large number of aged people.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2825
Aged people are more susceptible towards eye diseases, such as cataract and age-related macular degeneration. This aging population requires more effective ophthalmology devices for the treatment of eye diseases.
Moreover, several government associations are also increasing awareness towards ophthalmic diseases. Advancement in ophthalmology devices like mydriatic, non mydriatic fundus cameras and femtosecond lasers holds immense potential for growth of ophthalmology device market
However, various factors, such as lack of awareness towards eye diseases, high risks associated with the eye surgeries hamper the growth of ophthalmology devices market. In addition, there are some problems associated with the use of ophthalmology device such as changes made to the cornea can’t be reversed after LASIK surgery.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2825
Some of the major companies operating in the ophthalmology devices market are Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 10 Rating: 0.00 Votes: 0) Rate ItCancer is a disease characterized by abnormal growth of cell. These abnormal cells can infect other normal cells and tissues. Cancer cells can reach to other part of the body through blood and lymph system. There are more than 100 types of cancer and most of them are categorized by the organ, such as colon cancer and melanoma.
Biopsy is a medical test performed to examine and remove cancerous tissue from the body. When a patient is suspected to having cancer, biopsy is used to extract tissues sample for diagnosis of the disease. There are various types of biopsy used in diagnosis of cancers, such as shave biopsy, skin biopsy, incision & excision biopsy, fine needle aspiration, core needle biopsy and vacuum-assisted biopsy.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2820
Shave biopsy is performed with a scalpel blade or a curved razor blade to remove small fragment of skin for diagnosis of the disease. Fine needle aspiration biopsy is used to investigate superficial lumps or masses. A fine needle inserted into the body mass for isolation of infected cell and tissues for diagnosis of cancer.
In terms of geographic, North America is the largest market for global biopsy devices market followed by Europe and Asia. In North America, the U.S. holds the major share of biopsy devices market due to increasing prevalence of cancer.
This increasing prevalence of cancer requires biopsy procedures for diagnosis and treatment of the disease. In Europe, Germany, France and the U.K. are the largest countries for global biopsy devices market.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2820
Vacuum assisted biopsy procedure is the fastest growing biopsy procedure. This is one of the most important diagnostic methods for the diagnosis of breast cancer.
Lack of screening test for specific cancer, rising number of cancer patients and increased research and development activities in the field of biopsy devices are some of the major drivers for global biopsy devices market. According to National Cancer Institute (NCI), every year about 460 per 10,000 people are suffering from cancer.
However, stringent regulation and standards for the use of biopsy, clinical issues in core needle biopsy, increase complaints to breast cancer screening procedure are some of the key restraints for the global biopsy devices market. Moreover, high cost of biopsy devices is also impeding growth of global biopsy devices market.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2820
Some of the major companies operating in the biopsy devices market are The Boston Scientific Corporation, COOK Medical, CareFusion Corporation, DTR Medical, Devicor Medical Products, Inc., Gallini Srl, Hologic, Inc., and Cardinal Health, Inc.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 8 Rating: 0.00 Votes: 0) Rate ItA clinical decision support system is a part of clinical knowledge management technologies. It is an application which is used to analyze data to help healthcare providers make clinical decisions. A clinical decision support system can be used by nurses, physicians and healthcare providers to prepare and review diagnosis for improving final outcomes.
These systems are designed to incorporate patient data and medical knowledge base. There are two types of clinical decision support systems, first is knowledge base decision support systems and the other is without knowledge based decision support systems. Knowledge based decision support systems implement rules to patient data with the help of inference engine and demonstrate the results to the end user.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2811
Whereas, without knowledge based decision support systems depend on machine learning to analyze the clinical data.
North America dominates the global market for clinical decision support systems. This is due to early adoption by healthcare service providers, availability of advanced technologies and rising investment from healthcare IT players.
China, India and Japan are expected to show high growth rate, due to increase in aging population and rising number of chronic diseases. In addition, increase in government funding for healthcare IT systems are also expected to drive growth in these markets.
Some of the key drivers which are responsible for growth of clinical decision support systems market include rising aging population and rising government initiatives. In addition, growing need of integrated healthcare IT system, improved quality of care and clinical outcomes and rising incidence of various fatal diseases and medication errors are also expected to increase the demand of clinical decision support systems.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2811
However, lack of experienced professionals, privacy and security issues, interoperability issues and high maintenance and service expenses are some of the factors inhibiting the growth of clinical decision support systems market.
Emergences of cloud computing and increasing government initiatives have opened new opportunities for clinical decision support systems market. In addition, emerging markets such as China, Japan and India hold immense potential for the growth of clinical decision support systems.
Rising number of collaborations and partnerships by healthcare IT providers, increasing number of mergers and acquisitions and new products launches are some of the trends that have been observed in the clinical decision support systems market.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2811
Some of the major market players in clinical decision support systems include Agfa Healthcare, athenahealth, Inc., Allscripts Healthcare Solutions, Inc., Carestream Health, Inc., Cerner Corporation, GE Healthcare. In addition, McKesson Corporation, MEDITECH, NextGen Healthcare Information System LLC, Philips Healthcare and Siemens Healthcare also have significant presence in clinical decision support systems market.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 3 Rating: 0.00 Votes: 0) Rate ItNext generation sequencing is defined as a process of DNA sequencing decide the exact order of nucleotides inside a DNA molecule. Next generation sequencing allows rapid sequencing and produces a million DNA molecules and RNA sequences using next generation sequencer. Next generation sequencing is a high throughput sequencing. Next generation sequencing includes various modern sequencing technologies like Illumina sequencing and Roche 454 sequencing.
Next generation sequencing is not very costly and gives a high throughput for DNA sequencing compared to traditional Sanger’s sequencing method. Next generation sequencing applications are in the field of genetic disease research newborn sequencing metagenomics, personalized medicines, biological drug discovery, agriculture research, animal research and cancer research.
Also identification of binding sites on transcriptional factor, non-coding RNA expression profiling and re- sequencing of targets are some more applications of next generation sequencing.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2785
Increasing population, increasing incidences of cancer and transmissible diseases are expected to boost the next generation sequencing market attributing to the increased applications of next generation sequencing in the field of oncology and transmissible diseases.
The use of next generation sequencing in developing the personalized medicines at a genetic level, is projected to enhance the demand for next generation sequencing during the coming years. Increasing investments in research and development in the field of genomics, proteomics and metabolomics is expected to boost the next generation sequencing market. Introduction of new products and services by the key industry players is most likely to boost the next generation sequencing market in the coming years.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2785
Also, the inclination of scientists and drug developers is mostly pointing towards the next generation sequencing technique, to obtain genetic organization insights of a large number of organisms, is increasing the next generation sequencing market demand. Increase in growth of personal medicines, development in pre-sequencing and NGS bioinformatics solutions and cloud computing are some of the opportunities for global next generation sequencing market.
However, the storage and management of enormous data generated by sequencing and its interpretation are some of the challenges for global next generation sequencing market. Increasing number of collaboration and new product launches are some of the trends for global next generation sequencing market.
North America followed by the Europe dominates the global next generation sequencing market, due to rising government support towards research and development. Asia is expected to witness high growth in next generation sequencing due to rising investment in India and China on research and development of next generation sequencing.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2785
Some of the major companies operating in global next generation sequencing market are 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Inc., Biomatters, Ltd., CLC Bio, GATC biotech AG, Macrogen, Inc., BGI (Beijing Genomics Institute), Illumina, Inc., Life Technology Corporation, EMC Corporation and Dnastar, Inc.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 15 Rating: 0.00 Votes: 0) Rate ItIn-vitro diagnostics is a method of performing a diagnostic test to detect disease, condition or infection in an artificial environment. Molecular diagnostic is one of the major segments of in-vitro diagnostics market. Molecular diagnostics is used to measure and detect the presence of genetic material associated with specific disease. It is used to identify DNA and RNA at molecular level. Molecular diagnostics is a tool to improve clinical outcomes and medical decisions.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/2784
Molecular diagnostic includes all tests used to identify a disease, by analyzing molecules such as DNA, protein or RNA in a fluid or tissue. Nowadays molecular diagnostics is used in early detection of infectious diseases, cancer and genetic disorder, by using molecular and genetic technologies. Molecular diagnostics is also used in detection of abnormalities in pre-natal stage. In addition, molecular diagnostic kits are used in pharmacogenetics testing and blood donor screening.
North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market in North America.
Get TOC of This Report @ https://www.persistencemarketresearch.com/toc/2784
Asia is expected to show high growth rates in the next five years in molecular diagnostics market. Some of the factors driving growth of molecular diagnostics in emerging markets are increasing demand of genetic tests, advancement in healthcare infrastructure and large patient pool in countries such as India and China.
In recent times there is increased use of molecular diagnostics due to increasing application in blood screening, genetic disorders and cancer. Increasing prevalence of chronic and infectious diseases such as HIV and hepatitis, rising awareness and acceptance of personalized medicine and companion diagnostics are also fueling growth in the global molecular diagnostics market. However, changing reimbursement regulations and delayed approval of many new molecular diagnostic tests are some of the factors inhibiting the growth for global molecular diagnostics market.
Get Full Report @ https://www.persistencemarketresearch.com/checkout/2784
Growing demand for genetic tests is an opportunity for global molecular diagnostics market. However, strict regulatory framework and lack of skilled labor are some of the major challenges for global molecular diagnostics market. Some of the major companies operating in global molecular diagnostics market are Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
(Added: Thu Jan 28 2021 Hits: 7 Rating: 0.00 Votes: 0) Rate ItPages: [<<] ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... [>>]
Links SQL By: Gossamer Threads Inc.